New York, New York -- Aug 16, 2010 / (http://www.myprgenie.com) -- Van Leeuwenhoeck Research, Inc. (VLR) today announced that it has launched a new monthly magazine called LS Tribune. The new publication, edited by Founder and Chief Executive Officer Marcel Wijma, will detail news and developments in the global biotech and pharmaceutical industries.
“Readers of the LS Tribune include management of Life Sciences companies (listed and private companies) and investors (venture capital groups, angel investors and other institutional investors). Our platform provides a way for private companies in the global Life Sciences sector who seek financing to access the radar screen of investors. Essentially, the LS Tribune is a market place for supply and of investment ideas in Life Sciences,” said Wijma.
The latest issue of the LS Tribune includes articles on Sequencing the Human Genome, New Ways to Squash Superbugs, Blockbuster Potential in Cancer Treatments, and Phages versus Anibiotics: Battle for Bacteria. In addition, it profiles Genmab and YM Biosciences, new deals and partnerships, and trials and approvals.
The one-year subscription rate is $150US/EUR 100, which includes a free copy of either the annual US or European BioTech Guides, which profile the leading pharmaceutical companies.
VLR’s global platform is focused on providing institutional investors and other professional investors with independent, un-biased research on the real value of innovative life sciences companies. The VLR team conducts fundamental financial research, independently from any specific broker, bank, or investor.
In addition to the LS Tribune and annual BioTech Guides, VLR hosts investor and corporate seminars and other educational events and develops investor handbooks. A subscription service also provides detailed information on biotech companies that investors are tracking. This service is based on quarterly, in-depth research reports and a daily email service to keep subscribers informed about relevant news flow and issues that might trigger fluctuations in the price of the underlying securities.
For more information or to purchase a subscription, visit www.vanleeuwenhoeck.com or email info@vanleeuwenhoeck.com. To download a sample copy of the LS Tribune, please visit this link -- http://vanleeuwenhoeck.com/upload/docs/LST3def.pdf
To see press release go to http://myprgenie.com/8038
Contact: Charlotte Luer, 212 925 8703, cluer@ljhfm.com
To view this Press Release please go to http://www.myprgenie.com/publication/view_publication/vlr-announces-publication-of-ls-tribune?user_type=mc&ref_no=OTg0NTQ3%0A
To learn more about Van Leeuwenhoeck Research, Inc please go to http://www.myprgenie.com/company/profile/van-leeuwenhoeck-research-inc.
